chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 22-DEC-2015 at 23:50, the patient was vaccinated with improperly stored RECOMBIVAX HB with lot number: L025738, expiry date: unspecified (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. The high and low temperatures were 6.4 and 5.0 (units unspecified) respectively. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Client states a 4x6 inch red reaction.  States this reaction started 3/5/2021.   Reaction was not raised.  Hot to touch. Itchy.   Resolving  starting today.   3/4/2021 - Also felt like was "hit by truck"  for a couple days.
Arm pain, edema, redness (3.5 x 3.5 inches), chills, temp 99.2 with baseline normal of 97.2; fatigue, photo available
fatigue/tiredness on second day after shot; This is a spontaneous report from a contactable consumer (patient). A 90-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration at right arm on 30Jan2021 10:45 at single dose for COVID-19 immunization. Medical history included Congestive heart failure (CHF). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's concomitant medications were not reported. On 31Jan2021 13:00, the patient experienced fatigue/tiredness on second day after shot. No treatment was received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
COVID 19 treatment; COVID 19 treatment; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 64-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 22Sep2023 at 19:00 as dose 1, single (Batch/Lot number: unknown) at the age of 64 years, in left arm for COVID-19 immunisation. The patient's relevant medical history included: "Known allergies: Asparagus" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: bnt162b2 (dose 1, single; lot number: EW0153; site: left arm), administration date: 09Apr2021, when the patient was 62-year-old, for COVID-19 immunization; bnt162b2 (dose 2, single; lot number: EW0176; site: left arm), administration date: 30Apr2021, when the patient was 62-year-old, for COVID-19 immunization; bnt162b2 (dose 3 (booster), single; lot number: FH8027; site: left arm), administration date: 20Nov2021, when the patient was 62-year-old, for COVID-19 immunization; bnt162b2 (dose 4 (booster), single; lot number: unknown; site: left arm), administration date: 18Apr2022, when the patient was 63-year-old, for COVID-19 immunization; bnt162b2;bnt162b2 omi ba.4-5 (dose 5 (booster), single; lot number: GH9693; site: left arm), administration date: 14Sep2022, when the patient was 63-year-old, for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (07Oct2023) Negative. Therapeutic measures were taken as a result of drug ineffective, COVID-19. Additional information: The event was treated with Paxlovid from 01Oct2023 to 05Oct2023. 2 days after finishing Paxlovid course, the patient felt great and tested negative for COVID-19.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Narrative:  Patient with symptoms of stroke resulting in admission for evaluation of possible cause and medication changes to prevent future stroke. Patient elderly with hyperlipidemia and hypertension, so has other risk factors for stroke.
Rec'd call 840 AM 9/25/12 from client - stated she had high dose Flu Iz on 9/19/12 at 100 PM and by 500 PM she had slight diarrhea, headache, chills, cough, stomach ache - achy all over. Did not take her temp, S+S continued Thurs - a little better by Friday. Today (9/25/12) had diarrhea - watery - took Loperamide hydrochloride X 2 and Ibuprofen - advised her to see her MD today if not getting better.
This spontaneous report was received from a physician, via company representatives, and refers to a patient of unknown age and gender. Information about the patient's pertinent medical history, drug reactions/allergies and concomitant medications was not reported. On 18-DEC-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23, "10PK-0.5ml SD-PFS-LLok wTip" which had the lot # K009874 with expiration date 19-MAR-2016, (dosage number and route of administration were not reported). Nonetheless, no adverse effects were reported and no product quality complaint was involved. On an unspecified date, the vaccine experienced a temperature excursion of 32 F for 48 hours (lowest recorded temperature). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". This is one of the several reports received from the same reporter. Additional information has been requested.
Parents following alternative vaccine schedule. Came to office for PCV13 and asked nurse about  number of doses needed to be caught up. Nurse told mom needed 1 more dose of PCV13 in 4 weeks and 1 more Rota. Mom requested Rota be given on 6/25/19 and nurse gave it without checking previous date of last dose. Dose was given 6 days prior.
In the middle of April 2021, I went for a CT scan. The CT scan showed I had a new growth. The recommendation was to get a MRI. I had an MRI done around May 2021. It was determined that I had a new growth right next to my heart. It was diagnosed as a mediastinal tumor. I had surgery done at Hospital to remove the tumor by Doctor W.   The tumor was removed on June 18, 2021. The tumor was found to be benign. The surgery went well.
varicella - information has been received from a woman from a physician's office concerning a 5 year old female on 18 May 1998 was vaccinated Im in the left arm with one dose of varicella virus vaccine live.  On 16 Mar 2000 the patient experienced a mild case of chickenpox.  It was noted recovery expected.  No further information is available.
pt recvd vax & devel erythema, swelling & a macular rash @ the inject site; No further details were provided;
Approx 1 hour after vaccination,  pt. began feeling hot in her face. Face was red, noticed swelling (I was at lunch with co-worker). Assoc showed manager her face and was sent back to vaccination are. Brought to ED and given Benadryl. Initially had some itchiness in throat; resolved after Benadryl given.
Pt received Td booster 10/30/03 with immediate onset of R deltoid redness, heat, warmth and tenderness. 10/31/03 c/o intense general malaise, severe diffuse joint aches. R deltoid area continued to worsen. Pt went to walk in clinic with above complaints 3 days after injection. Didn't feel cellulitis was present. As of 11/31/03 mild R deltoid soreness continues.
first a luttle fever, then rash in the body on Saturday with itch. On Sunday, the rash was there but mild Ob Monday, around 12:00 start to itch again and the rash was medium. Need to provide a Benadryl to calm the itch.
Tightness in chest, throat closing up, high blood pressure, tingling in right fingers, shortness of breath, cheeks, forehead, chest got red.
Headaches, slight stomach pain, intestinal cramping, and low energy,  For 3 weeks
The first symptom I experienced was an intense sense of deja vu and recalling random memories. This lasted strongly for three days. This symptom has continued but decreased in intensity. I had this same feeling about two weeks after the first dose of the vaccine on 3/23/21, but to a much lesser degree. After about two weeks from the date of vaccination, I started to feel tingling and cold sensations throughout my entire body (including tongue and throat). I had this same feeling after the first dose of the vaccine on 3/23/21, but only on my face. These sensations subsided within a few weeks after the first vaccine dose. However, after the second dose, they took months to subside. Around the time that the tingling sensations began, I developed insomnia. I would wake up during the night completely alert and feeling hyperactive. I also experienced very vivid dreams. The insomnia has gone away. I would also experience jolting, electrical sensations shooting down my arms and legs that would wake me up during the night. The sensations dissipated over about two months? time. I?ve also experienced GI symptoms since about a week after the date of vaccination.
Burning rash on the face and elbows; softball-size redness/hard painful at the site.
Fever, Headache, Fatigue from the next morning (Friday) until the following morning (Saturday). I ended up sleeping about 8 hours total (not including morning and night). When awake I had a 102 fever on average with a terrible headache and fatigue.
Patient received the newest dose of Comirnaty. Within few minutes she has fainted. Ambulance was called and patient was taken to a hospital. Patient's daughter stepped by the pharmacy about an hour later and informed us that EMT team/hospital MD believe patient had a reaction to the vaccine. She is still in the hospital for an observation. Patient reports weakness in her legs, feeling shaky, and out of it.
Sore left arm for a week, headaches and very very extreme fatigue. I've only been outside twice since my vaccination. I lost interest in things that I use to do.  The fatigue is still ongoing since the vaccination.
arm redness, rash, warmth at injection site 2.5 X 3" site
neck and shoulder pain; neck and shoulder pain; This is a spontaneous report from a contactable nurse via Medical information team. A female patient of an unspecified age (Age: 42 Unit: Unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose on Monday and experienced neck and shoulder pain on unspecified date. The patient has been seen at Employee Health but indicated that the effect appeared to be worsening. The patient was transferred to receive indication of whether to receive second dose and if this was a serious adverse event. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Patient was tired, started running fever, shortness of breath, coughing, oxygen level drops when doing simple tasks. Patient is still running fever some days.
Axillary tenderness on day 6, then gradual worsening of swelling, pain and erythema on left deltoid for a few days after. Then swelling and pain resolved but rash is spreading and now itchy.
This spontaneous report as received from a registered nurse refers to patients with unknown age and sex. On an unknown date patients were vaccinated with VARIVAX (Merck) (lot#, route and dose unknown) which had been exposed to temperatures above 5 Fahrenheit. No adverse experience had been reported. It was not specified if patients sought for medical attention. This is one of several reports received from the same reporter. Additional information has been requested.
Pain - injection administered (L) arm SC. Erythema approximately 20 cm. Encouraged to apply warm compress & TYLENOL for pain if needed.
Patient came to the clinic over two weeks after pfizer-bionTech Covid vaccine with shingles and treated with Valtrex 1000mg po TID for 7 days. Her next scheduled dose is in two days, 2/17/2021.
This spontaneous report as received from a nurse, refers to unspecified number of patients of unknown demography. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patients were vaccinated with improperly stored GARDASIL 9 injection (strength, dose, route and lot number or batch number unspecified). No concomitant medications were reported. No symptoms were reported. The outcome of the event was unknown. There were no product quality complaint (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Painful; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was patient's sibling. The age at vaccination was not reported. The patient had received shingles vaccine and experienced pain. The follow-up would not possible as no contact details were available.  This case had been linked with US2021AMR066108 and US2021AMR066116 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR066116:Father's case US-GLAXOSMITHKLINE-US2021AMR066108:Reporter's case
Fever (Tmax 103), body tremors for 24 hours, Rx: TYLENOL and MOTRIN.
This spontaneous report was received from a nurse and refers to multiple patients of unknown age and gender. The patient's medical histories and concurrent conditions were not reported. On multiple unknown dates, the patients were vaccinated with improperly stored doses of PEDVAXHIB (dose and route of administration were not reported) (Lot # L030867; expiration date 09-MAY-2018. Concomitant medications were not reported. No adverse effects reported. The PEDVAXHIB highest reached temperature was 52.5F for a time frame of 2 Hours and 54 minutes. Additional information has been requested.
Muscle aches and Fever. Fever details:  My normal temp is 98.1-98.2; this was my temp as of approx 8pm after 2pm vaccine By midnight: 99.8F 2 am: 99.9F 3am: 100.5F 6am: 99.6F 8am: 97.6F (fever gone)
I started having really sharp pains in her chest and they may last for about 30 seconds or so. Then it goes away. So it continued and we made an appointment with her pediatrician and the doctor referred us to the Pediatric Cardiologist.
Reports to ED 2 days after first Pfizer vaccine with SOB, chest pain, headache, fatigue. Normal EKG and troponin, normal D-dimer. Likely normal vaccine reaction. Discharged home in stable condition. 3 days later presents to PCP, still symptomatic and now with tingling all over body and slight numbness to right side of face and arm. No deficits, likely extended vaccine reaction.
Patient (my son) developed a 5x6 in warm, indurated, painful area just below and distal to the injection site, but not circumferential on day 2.  Treated with cold compresses and eventually resolved 6 days after first appeared.  No associated fevers, sensation intact, no concern for compartment syndrome.  Myself (a pediatrician) monitored him carefully at home.
She was vaccinated on 09/23/2009 and from 09/25/2009 she started feeling sick and was seen by a doctor at doctor's office ENT department. She was diagnosed with a sinus infection and treated with antibiotics and prednisone.
Hives; itching; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 73 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 04Feb2021 (Lot number: EM9810) at the age of 72 years as dose 2, single for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), administration date 04Feb2021 (Batch/Lot number: unknown). Relevant medical history included: "Verbatim: Colitis" (unspecified if ongoing), notes: Diagnosed 15 years ago. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1, Lot: EL3249), administration date: 14Jan2021, when the patient was 72 years old, for Covid-19 immunization. The following information was reported: URTICARIA (non-serious), outcome "not recovered", described as "Hives"; PRURITUS (non-serious), outcome "not recovered", described as "itching". The events "hives" and "itching" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Concomitant Products: everything that she has been taking she has been on for years. Caller adds that when she talked to my doctor about it, he told her it wasn't a side effect and asked if she was still itching. Which she states she is still itching, but the Budinsoid helped her colitis. She has big red welts and confirms those are the hives. Nothing has changed. Patient was not administered any Prior Vaccinations    No follow-up attempts are possible. No further information is expected.
Information has been received from a doctor of pharmacy concerning a 61 year old female patient who on 05-NOV-2008 was vaccinated with a dose of ZOSTAVAX (Merck) (lot # 653197/1418X).  On 06-NOV-2008 the patient experienced intense pain, redness and swelling from the shoulder ot the elbow. On approximately 08-NOV-2008 the patient recovered.  This is one of two reports received from the same source.  Additional information is not expected.
Information has been received from a medical assistant referring to a 14 year old male patient. On 20-AUG-2014, the patient was vaccinated with the first dose of GARDASIL (lot # and route unknown). On 26-AUG-2015, the patient was in the office to be vaccinated with second dose of GARDASIL. No adverse effects reported. Additional information has been requested.
About 6 weeks after the second dose of the COVID-19 vaccine - vitiligo (white patches) started to emerge. The onset was quick and appeared all over my daughter's body.  It is still present
Chills with shaking, nausea, fever (101.5°), body aches
Patient had accidentally received an expired dose of Infanrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 3-year-old female patient who received DTPa (Infanrix) (batch number 7ec55, expiry date 29-APR-2023) for prophylaxis.   On 18-MAY-2023, the patient received Infanrix. On 18-MAY-2023, an unknown time after receiving Infanrix, the patient experienced expired vaccine used (Verbatim: Patient had accidentally received an expired dose of Infanrix). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 19-MAY-2023 The reporter was an office manager. The patient had accidentally received an expired dose of Infanrix, which led to expired vaccine used. The reporter wished to know how to proceed. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up.
Patient had a cellulitis reaction same day of vaccine. Cellulitis reaction measured 8.4 in x 6 in.
p/receiving vax 12N @ clinic pt returned to work; states substained a neck injury 130PM @ work; c/o of stiffness of neck & shoulders; seen @ ER then hospitalized x 10 days; states no definite diagnosis made;
Narrative: He reports deveoping an egg-sized area of erythema over past vacciation site a/w mild puritus 3 days after the injection. This area persisted for ~ 2 weeks. It was not associated with swelling, induration, hives, urticaria, warmth to touch. He denies other common vaccination adverse effects and did not apply or try any therapies for the itching.
Chills, fever, strong headache, muscle ache, nausea and vomiting; onset about 12 hours after vaccination.  Chills and fever gone after about 36 hours after vaccination, persistant strong headache. Sore throat, runny nose about 24 hours after vaccination. Pain in right arm, onset about 36 hours after vaccination.
Received injection approximately 11:15 a.m. on April 7th 2021. At approximately 2:00 p.m. begin to feel a flush like feeling of warmth in the face.  Very mild headache developed, which strengthened to moderate throughout the afternoon.  Arm soreness begin to develop. Took ibuprofen 400 mg at approximately 9:00 p.m. headache subsided. At approximately 7:00 a.m. , April 8th 2021, headache developed to moderate condition. And 8:00 a.m. took ibuprofen 400 mg at 9:15 a.m. headache subsiding.
Initial unsolicited report received from a pharmacist on 28 September 2015. This case involves a (81-year-old) female patient who was vaccinated with a [dose not reported] intramuscular [dose series not reported] dose of FLUZONE HD (batch number UI448AA, expiry date not reported) in left deltoid 26 September 2015. Patient had no illness at time of vaccination and pre-existing physician diagnosed allergies, birth defects, medical conditions (specify) was reported as no known allergy (NKA) and patient had received CRESTOR, SINGULAIR "cingulair", lorazepam "Lorzepam", ropinorole "Ropeneral". Concomitant medications were not reported. On 26 September 2015, same day following the vaccination patient had developed injection site red, bruising from deltoid to bicep, warm to touch. Patient laboratory investigation and corrective treatment was not reported. The outcome of event was not recovered. Follow up information received from physician on 10 December 2015. No new information reported. List of documents held by sender: none.
Fever (101), chills, body aches and headache started approximately 20 hours after the dose was given. Acetaminophen taken.  Fever and chills resolved by next day;  mild body aches persisting next day.
Patient initially complained of itching, then head swimming, passed out, said had trouble breathing, hard to swallow.
notable rash on scalp, arms & legs of pt 2-3min p/vax given;
Per Pt had received immunizations around 11:00am (TDaP, MCV4, VAR, Hep A, HPV).  Pt had stayed 15mins after immunizations were given and was ok before left off-site clinic-per Mom.   After left off-site clinic, went walking around school and then to the bank, after got at the bank Pt started c/o of sore throat so Mom got Pt a soda and she consumed 1/2 of it-per Mom.  At 11:50am Mom had brought Pt back to off-site clinic.  Pt was c/o runny nose, cough, HA, shake, dizzy, and sore/tight throat.  Pt assessment done-sitting in chair, skin color pink and dry, lungs CTA, resp rate strong and regular, no cough noted, heart sounds strong and regular, nail beds pink, oriented x3.  Pt stated she had only eaten 1/2 cup turkey salad at 8:30am today.  Mom stated Pt has history of seasonal allergies and asthma, but no asthma flare-up since 6yrs of age.  Pt was monitored for approx 30mins, still no resp distress noted.  Pt stated she felt some better before leaving off-site clinic again.  Mom was instructed if Pt was to have this episode again to go to the nearest ER or seek medical attention and would need to get next imm at doctor office.  Mom verbalized understanding.  Mom stated she was going to get Pt some OTC Benadryl to have at home in case.